ATOR-1144

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameATOR-1144

Drug Alias NameATOR-1144

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionGlucocorticoid-induced tumor necrosis factor receptor-related protein inhibitorsCytotoxic T-Lymphocyte-Associated Antigen 4 inhibitors

TargetsGlucocorticoid-induced tumor necrosis factor receptor-related proteinCytotoxic T-Lymphocyte-Associated Antigen 4

Therapy Area/IndicationsHematologic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAlligator Bioscience Ab

China Registration ClassN/A

Develop Information

Active CompaniesAlligator Bioscience Ab

Inactive CompaniesN/A

Active IndicationsHematologic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A